Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 2, 1996, Pages 124-127

  Conti, F ^a   Magrini, L ^a   Priori, R ^a   Valesini, G ^a   Bonini, S ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Allergy; Chronic fatigue syndrome; Eosinophil cationic protein; RAST

Indexed keywords

PROTEIN;

ADULT; ALLERGY; ARTICLE; BLOOD LEVEL; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST;

EID: 0029900529     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb00047.x     Document Type: Article

References (32)

1. Fukuda K, Straus SE, Hickie IH, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-9.
2. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988;108:387-9.
3. Schluederberg A, Straus SE, Peterson P, et al. Chronic fatigue syndrome research: definition and medical outcome assessment. Ann Intern Med 1992;117:323-31.
4. Conti F, Priori R, De Petrillo G, Rusconi AC, Arpino C, Valesini G. Prevalence of chronic fatigue syndrome in Italian patients with persistent fatigue. Ann Ital Med Int 1994;9:219-22.
5. Klonoff DC. Chronic fatigue syndrome. Clin Infect Dis 1992;15:812-23.
6. Valesini G, Conti F, Priori R. Chronic fatigue syndrome: what factors trigger it off? Clin Exp Rheumatol 1994;12:473-6.
7. Bond PA. A role for herpes simplex virus in the aetiology of chronic fatigue syndrome and related disorders. Med Hypotheses 1993;40:301-8.
8. Wray BB, Gaughf C, Chaldler FW, et al. Detection of Epstein-Barr virus and cytomegalovirus in patients with chronic fatigue. Ann Allergy 1993;71:223-6.
9. Fenske TK, Davis P, Aaron SL. Human adjuvant disease revisited: a review of eleven post-augmentation mammoplasty patients. Clin Exp Rheumatol 1994;12:477-81.
10. Priori R, Conti F, Luan FL, Arpino C, Valesini G. Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with l-tryptophan in four Italian adolescents. Eur J Pediatr 1994;153:344-6.
11. Bell KM, Cookfair B, Bell DS, Reese P, Cooper L. Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases. Rev Infect Dis 1991;130 Suppl. 1: s32-8.
12. Straus SE, Dale JK, Wright R, Metcalfe DD. Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol 1988;81:791-5.
13. Fukuda T, Gleich GJ. Heterogeneity of human eosinophils. J Allergy Clin Immunol 1989;83:369-73.
14. Dvorak AM, Ackerman SJ, Weller PF. Subcellular morphology and biochemistry of eosinophils. In: Harris JR, editor. Blood cell biochemistry. Vol. 2. Megakaryocytes, platelets, macrophages and eosinophils. London: Plenum, 1990;237-44.
15. Venge P, Dahl R, Fredens K, Hallgren R, Peterson C. Eosinophil cationic proteins (ECP and EPX) in health and diseases. In: Yoshida T, Torisu M, editors. Immunobiology of the eosinophil. New York: Elsevier Biochemical, 1983: 163-79.
16. Bonini S, Tomassini M, Bonini S, Capron M, Balsano F. The eosinophil has a pivotal role in allergic inflammation of the eye. Int Arch Allergy Immunol 1992;99:354-8.
17. Bonini S, Tomassini M, Adriani E, et al. Markers of eosinophilic inflammation in allergic diseases. Allergy 1993;48:133-7.
18. Juhlin L, Venge P. Eosinophil cationic protein (ECP) in skin disorders. Acta Derm Venereol (Stockh) 1991;71:495-501.
19. Matsson P, Ahlstedt S, Enander I, Peterson CGB, Venge P. Measurement of specific markers in the monitoring of the bronchial inflammation in asthma. Ann N Y Acad Sci 1991;629:383-7.
20. McLaren DJ, Peterson CGB, Venge P. Schistosoma mansoni: further studies of the interaction between schistosomula and granulocyte-derived cationic proteins in vitro. Parasitology 1984;88:491-503.
21. Roitt IM. Immunity to infection. In: Roitt IM. Essential immunology. Oxford: Blackwell, 1977:189.
22. Tomassini M, Magrini L, Bonini S, Lambiase A, Bonini S. Increased serum levels of eosinophil cationic protein and eosinophil derived neurotoxin (protein X) in vernal kerato-conjunctivitis. Ophthalmology 1994;101:1808-11.
23. Barbee W, Lebowitz C, Thompson HC, Borrows B. Immediate skin-test reactivity in a general population sample. Ann Int Med 1976;84:129.
24. Bonini S, Rosa C, Rasi G, Falagiani P, Simoni L, Zaffiro A. IgE sieriche totali e specifiche in soggetti apparentemente sani con e senza familiarità allergologica. Folia Allergol Immunol Clin 1980;27:261-8.
25. Hallgren R, Venge P. The eosinophil in inflammation. In: Matsson P, Ahlstedt S, Venge P, Thorell J, editors. Clinical impact of the monitoring of allergic inflammation. London: Academic Press, 1991:119-40.
26. Peterson CGB, Skoog V, Venge P. Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation. Immunobiology 1986;171:1-13.
27. Fredens K, Dahl R, Venge P. The Gordon phenomenon induced by eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol 1982;70:361.
28. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 1992;47:450-5.
29. Romagnani S. Human Th1 and Th2 subsets: doubt no more. Immunol Today 1991;12:256-7.
30. McKenzie ANJ, Sanderson CJ. Interleukin-5. In: Kishimoto T, editor. Interleukins: molecular biology and immunology. Chem Immunol 1992;51:135-52.
31. Linde A, Andersson B, Svenson SB, et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infections and in patients with chronic fatigue syndrome. J Infect Dis 1992;165:994-1000.
32. Straus SE, Dale JK, Peter JB, Dinarello CA. Circulating lymphokine levels in the chronic fatigue syndrome. J Infect Dis 1989;160:1085-6.